Sociedad Americana de Hirudoterapia

Cutaneous pseudolymphoma as a rare adverse effect of medicinal leech therapy: a case report and review of the literature

Case report published in Cureus (2020)

Última actualización: June 18, 2026Revisado por: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Case reportSeguridad y control de infeccionesEnsayos clínicosSepaskhah M et al. · Cureus, 2020

Abstract

Hirudotherapy (leech therapy) is one of the oldest practices in medical history, and nowadays it is used for several purposes in medicine. Salvage of flaps, wound healing, pain management, and treatment of varicose veins are among the common therapeutic applications of leeches. Complications associated with leech therapy include infections, bleeding, anemia, and allergic reaction. Cutaneous pseudolymphoma (benign proliferation of lymphoid cells in the skin) follows several underlying conditions. Although persistent arthropod bite reaction is one of the conditions associated with cutaneous pseudolymphoma, it has been rarely reported after medicinal leech therapy. Here we describe the case of a patient who presented with cutaneous pseudolymphoma after leech therapy as a rare cutaneous complication of hirudotherapy.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeCase ReportsJournal Article

Resumen

Case of cutaneous pseudolymphoma after hirudotherapy, reviewing the rare adverse-effect spectrum (infection, bleeding, anemia, allergic reactions, pseudolymphoma) of leech therapy.

Por qué esto importa para la hirudoterapia

This case report describes a patient who developed cutaneous pseudolymphoma—a benign proliferation of lymphoid cells in the skin—as a rare cutaneous complication following medicinal leech therapy. The abstract notes that hirudotherapy is used for flap salvage, wound healing, pain management, and varicose vein treatment, and that known complications include infections, bleeding, anemia, and allergic reactions, with cutaneous pseudolymphoma being a rarely reported additional adverse effect. This is directly relevant to ASH's domain as it documents a cutaneous safety concern of hirudotherapy. The primary limitation is that this is a single case report of an uncommon reaction, so no generalizable incidence data or risk factors can be inferred from the abstract.

Citación

Cutaneous pseudolymphoma as a rare adverse effect of medicinal leech therapy: a case report and review of the literature.

Sepaskhah M et al. · Cureus, 2020

Contexto clínico relacionado

Añadido a la biblioteca ASH: May 27, 2026 · Última actualización del sitio: June 18, 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.